1648 related articles for article (PubMed ID: 12065756)
1. SB-431542 is a potent and specific inhibitor of transforming growth factor-beta superfamily type I activin receptor-like kinase (ALK) receptors ALK4, ALK5, and ALK7.
Inman GJ; Nicolás FJ; Callahan JF; Harling JD; Gaster LM; Reith AD; Laping NJ; Hill CS
Mol Pharmacol; 2002 Jul; 62(1):65-74. PubMed ID: 12065756
[TBL] [Abstract][Full Text] [Related]
2. SB-505124 is a selective inhibitor of transforming growth factor-beta type I receptors ALK4, ALK5, and ALK7.
DaCosta Byfield S; Major C; Laping NJ; Roberts AB
Mol Pharmacol; 2004 Mar; 65(3):744-52. PubMed ID: 14978253
[TBL] [Abstract][Full Text] [Related]
3. Growth differentiation factor-9 signaling is mediated by the type I receptor, activin receptor-like kinase 5.
Mazerbourg S; Klein C; Roh J; Kaivo-Oja N; Mottershead DG; Korchynskyi O; Ritvos O; Hsueh AJ
Mol Endocrinol; 2004 Mar; 18(3):653-65. PubMed ID: 14684852
[TBL] [Abstract][Full Text] [Related]
4. The ALK-5 inhibitor A-83-01 inhibits Smad signaling and epithelial-to-mesenchymal transition by transforming growth factor-beta.
Tojo M; Hamashima Y; Hanyu A; Kajimoto T; Saitoh M; Miyazono K; Node M; Imamura T
Cancer Sci; 2005 Nov; 96(11):791-800. PubMed ID: 16271073
[TBL] [Abstract][Full Text] [Related]
5. Adenoviral gene transfer allows Smad-responsive gene promoter analyses and delineation of type I receptor usage of transforming growth factor-beta family ligands in cultured human granulosa luteal cells.
Kaivo-Oja N; Mottershead DG; Mazerbourg S; Myllymaa S; Duprat S; Gilchrist RB; Groome NP; Hsueh AJ; Ritvos O
J Clin Endocrinol Metab; 2005 Jan; 90(1):271-8. PubMed ID: 15483083
[TBL] [Abstract][Full Text] [Related]
6. Transforming growth factor-beta- and Activin-Smad signaling pathways are activated at distinct maturation stages of the thymopoeisis.
Rosendahl A; Speletas M; Leandersson K; Ivars F; Sideras P
Int Immunol; 2003 Dec; 15(12):1401-14. PubMed ID: 14645149
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of transforming growth factor (TGF)-beta1-induced extracellular matrix with a novel inhibitor of the TGF-beta type I receptor kinase activity: SB-431542.
Laping NJ; Grygielko E; Mathur A; Butter S; Bomberger J; Tweed C; Martin W; Fornwald J; Lehr R; Harling J; Gaster L; Callahan JF; Olson BA
Mol Pharmacol; 2002 Jul; 62(1):58-64. PubMed ID: 12065755
[TBL] [Abstract][Full Text] [Related]
8. Selective inhibition of activin receptor-like kinase 5 signaling blocks profibrotic transforming growth factor beta responses in skin fibroblasts.
Mori Y; Ishida W; Bhattacharyya S; Li Y; Platanias LC; Varga J
Arthritis Rheum; 2004 Dec; 50(12):4008-21. PubMed ID: 15593186
[TBL] [Abstract][Full Text] [Related]
9. TGF-(beta) type I receptor/ALK-5 and Smad proteins mediate epithelial to mesenchymal transdifferentiation in NMuMG breast epithelial cells.
Piek E; Moustakas A; Kurisaki A; Heldin CH; ten Dijke P
J Cell Sci; 1999 Dec; 112 ( Pt 24)():4557-68. PubMed ID: 10574705
[TBL] [Abstract][Full Text] [Related]
10. Bone morphogenetic proteins.
Chen D; Zhao M; Mundy GR
Growth Factors; 2004 Dec; 22(4):233-41. PubMed ID: 15621726
[TBL] [Abstract][Full Text] [Related]
11. Activin receptor-like kinase (ALK)1 is an antagonistic mediator of lateral TGFbeta/ALK5 signaling.
Goumans MJ; Valdimarsdottir G; Itoh S; Lebrin F; Larsson J; Mummery C; Karlsson S; ten Dijke P
Mol Cell; 2003 Oct; 12(4):817-28. PubMed ID: 14580334
[TBL] [Abstract][Full Text] [Related]
12. Stimulation of Smad1 transcriptional activity by Ras-extracellular signal-regulated kinase pathway: a possible mechanism for collagen-dependent osteoblastic differentiation.
Suzawa M; Tamura Y; Fukumoto S; Miyazono K; Fujita T; Kato S; Takeuchi Y
J Bone Miner Res; 2002 Feb; 17(2):240-8. PubMed ID: 11811554
[TBL] [Abstract][Full Text] [Related]
13. Engagement of activin and bone morphogenetic protein signaling pathway Smad proteins in the induction of inhibin B production in ovarian granulosa cells.
Bondestam J; Kaivo-oja N; Kallio J; Groome N; Hydén-Granskog C; Fujii M; Moustakas A; Jalanko A; ten Dijke P; Ritvos O
Mol Cell Endocrinol; 2002 Sep; 195(1-2):79-88. PubMed ID: 12354674
[TBL] [Abstract][Full Text] [Related]
14. Bone morphogenetic protein signaling in articular chondrocyte differentiation.
Nishihara A; Fujii M; Sampath TK; Miyazono K; Reddi AH
Biochem Biophys Res Commun; 2003 Feb; 301(2):617-22. PubMed ID: 12565908
[TBL] [Abstract][Full Text] [Related]
15. The orphan receptor serine/threonine kinase ALK7 signals arrest of proliferation and morphological differentiation in a neuronal cell line.
Jörnvall H; Blokzijl A; ten Dijke P; Ibáñez CF
J Biol Chem; 2001 Feb; 276(7):5140-6. PubMed ID: 11084022
[TBL] [Abstract][Full Text] [Related]
16. Identification of novel inhibitors of the transforming growth factor beta1 (TGF-beta1) type 1 receptor (ALK5).
Callahan JF; Burgess JL; Fornwald JA; Gaster LM; Harling JD; Harrington FP; Heer J; Kwon C; Lehr R; Mathur A; Olson BA; Weinstock J; Laping NJ
J Med Chem; 2002 Feb; 45(5):999-1001. PubMed ID: 11855979
[TBL] [Abstract][Full Text] [Related]
17. Elucidation of Smad requirement in transforming growth factor-beta type I receptor-induced responses.
Itoh S; Thorikay M; Kowanetz M; Moustakas A; Itoh F; Heldin CH; ten Dijke P
J Biol Chem; 2003 Feb; 278(6):3751-61. PubMed ID: 12446693
[TBL] [Abstract][Full Text] [Related]
18. Preclinical Evaluation of AZ12601011 and AZ12799734, Inhibitors of Transforming Growth Factor
Spender LC; Ferguson GJ; Hughes GD; Davies BR; Goldberg FW; Herrera B; Taylor RG; Strathearn LS; Sansom OJ; Barry ST; Inman GJ
Mol Pharmacol; 2019 Feb; 95(2):222-234. PubMed ID: 30459156
[TBL] [Abstract][Full Text] [Related]
19. Conversion of SB 203580-insensitive MAP kinase family members to drug-sensitive forms by a single amino-acid substitution.
Eyers PA; Craxton M; Morrice N; Cohen P; Goedert M
Chem Biol; 1998 Jun; 5(6):321-8. PubMed ID: 9653550
[TBL] [Abstract][Full Text] [Related]
20. Activin receptor-like kinase-7 induces apoptosis through activation of MAPKs in a Smad3-dependent mechanism in hepatoma cells.
Kim BC; van Gelder H; Kim TA; Lee HJ; Baik KG; Chun HH; Lee DA; Choi KS; Kim SJ
J Biol Chem; 2004 Jul; 279(27):28458-65. PubMed ID: 15107418
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
